Bispecific Antibody-Bound T Cells as a Novel Anticancer Immunotherapy

Chimeric antigen receptor T (CAR-T) cell therapy is one of the promising anticancer treatments. It shows a high overall response rate with complete response to blood cancer. However, there is a limitation to solid tumor treatment. Additionally, this currently approved therapy exhibits side effects s...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Jaewon, Tae, Nara, Ahn, Jae-Hee, Chang, Sun-Young, Ko, Hyun-Jeong, Kim, Dae Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Applied Pharmacology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424331/
https://www.ncbi.nlm.nih.gov/pubmed/35577765
http://dx.doi.org/10.4062/biomolther.2022.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424331/
https://www.ncbi.nlm.nih.gov/pubmed/35577765
http://dx.doi.org/10.4062/biomolther.2022.015

Ejemplares similares